Department of Pediatrics, Hamad Medical Corporation, Qatar University, Doha, Qatar.
Microbiology Division, Department of Laboratory Medicine and Pathology, Hamad Medical Corporation, Qatar University, Doha, Qatar.
Infect Drug Resist. 2014 Nov 20;7:309-16. doi: 10.2147/IDR.S72112. eCollection 2014.
Pseudomonas aeruginosa is one of the primary pathogens isolated more frequently in cystic fibrosis (CF) and it exhibits innate resistance to a wide range of antibiotics.
We sought to determine whether the highly prevalent genotypes of P. aeruginosa are specifically linked to CF patients and have any related multidrug antibiotic resistance. Isolates from hospitalized non-CF patients and from environmental sources were also genotypically analyzed.
Collections of P. aeruginosa from lower respiratory secretions (n=45) were genotyped using pulsed-field gel electrophoresis (PFGE). Phenotypic screening for antibiotic susceptibility was performed for the common antimicrobial agents by E-test and automated Phoenix method.
P. aeruginosa isolates from CF (n=32), hospitalized non-CF patients (n=13), and environment sources (n=5) were analyzed. The population structure of P. aeruginosa is highly diverse and population-specific. All PFGE results of P. aeruginosa isolates fall among four major clusters. Cluster 1 contained 16 P. aeruginosa isolates from CF patients and two from environmental sources; cluster 2 contained 11 P. aeruginosa isolates from CF and one each from non-CF and environmental sources; cluster 3 contained 12 P. aeruginosa isolates from hospitalized non-CF patients and two P. aeruginosa isolates from one CF patient and one environmental source; and cluster 4 consisted of three isolates from CF patients and one from the environment. The majority of multidrug-resistant P. aeruginosa isolates were in clusters 3 and 4. P. aeruginosa isolates from CF patients were resistant to ciprofloxacin (34.4%) followed by resistance to amikacin and gentamicin (each 28%), whereas the majority of isolates from non-CF patients were resistant to meropenem (69%) and were grouped in cluster 3.
PFGE of P. aeruginosa isolates from CF patients shows a high degree of similarity, suggesting specific adaptation of these clones to CF-affected lungs. The hospitalized non-CF cluster has a different clonal origin, indicating specific clustering in a specific location, suggesting hospital-acquired P. aeruginosa infections.
铜绿假单胞菌是在囊性纤维化(CF)中更频繁分离到的主要病原体之一,它对广泛的抗生素表现出固有耐药性。
我们试图确定铜绿假单胞菌的高流行基因型是否专门与 CF 患者相关,以及它们是否具有相关的多药抗生素耐药性。还对住院非 CF 患者和环境来源的分离株进行了基因分型分析。
使用脉冲场凝胶电泳(PFGE)对来自下呼吸道分泌物的铜绿假单胞菌(n=45)进行基因分型。通过 E 试验和自动 Phoenix 方法对常见抗菌药物进行抗生素敏感性表型筛选。
对来自 CF(n=32)、住院非 CF 患者(n=13)和环境来源(n=5)的铜绿假单胞菌分离株进行了分析。铜绿假单胞菌的种群结构高度多样化且具有种群特异性。所有铜绿假单胞菌分离株的 PFGE 结果均属于四个主要聚类。聚类 1 包含 16 株来自 CF 患者的铜绿假单胞菌和来自环境的 2 株;聚类 2 包含 11 株来自 CF 的铜绿假单胞菌和来自非 CF 和环境的各 1 株;聚类 3 包含 12 株来自住院非 CF 患者的铜绿假单胞菌和来自 1 位 CF 患者和 1 位环境来源的各 2 株;聚类 4 由来自 CF 患者的 3 株和来自环境的 1 株组成。大多数多药耐药铜绿假单胞菌分离株在聚类 3 和 4 中。CF 患者的铜绿假单胞菌分离株对环丙沙星(34.4%)耐药,其次是对阿米卡星和庆大霉素(各 28%)耐药,而非 CF 患者的大多数分离株对美罗培南(69%)耐药,并聚类在聚类 3 中。
CF 患者铜绿假单胞菌分离株的 PFGE 显示出高度的相似性,表明这些克隆对 CF 受累肺部有特定的适应性。住院非 CF 聚类具有不同的克隆起源,表明在特定位置发生了特定聚类,提示医院获得性铜绿假单胞菌感染。